Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species.

Comparison of the in-vitro and in-vivo efficacy of FK037, vancomycin, imipenem and nafcillin against staphylococcal species.
复制标题

FK037、万古霉素、亚胺培南和萘夫西林对葡萄球菌的体外和体内疗效比较。

DOI:
10.1093/jac/40.1.59
复制
发表时间:
1997
期刊:
The Journal of antimicrobial chemotherapy
影响因子:
--
通讯作者:
Archer,GL
Archer,GL
中科院分区:
--
文献类型:
--
作者:
Climo,MW;Markowitz,SM;Williams,DS;Hale-Cooper,CG;Archer,GL

文献摘要

参考文献

被引文献

相似文献

The activity of methicillin, oxacillin, vancomycin, imipenem and FK037 against 106 isolates of staphylococci was assessed using a microbroth dilution method with low (10(5) cfu/mL) and high (10(7) cfu/mL) inoculum sizes. Overall, FK037, an oxime-type cephem antibiotic, was as active as imipenem, but less active than vancomycin (MIC90s 25, 25 and 6.25 mg/L, respectively) at the lower inoculum. Efficiency of plating experiments were also performed to characterize phenotypic expression of resistance to FK037, imipenem and methicillin. Five of 24 isolates and 18 of 24 isolates contained subpopulations resistant to FK037 and imipenem, respectively. In a rabbit model of endocarditis, FK037 was equally effective as other antibiotics tested in the treatment of methicillin-sensitive Staphylococcus aureus infection. In the treatment of endocarditis due to a homotypic methicillin-resistant S. aureus, FK037 and vancomycin were the most active antibiotics. The presence of subpopulations resistant to imipenem and FK037, as demonstrated by efficiency of plating and high inoculum MIC testing, did not correlate with antibiotic effectiveness in the rabbit model of endocarditis. Cultures of vegetation material following treatment with imipenem and FK037 demonstrated a lower frequency of organisms resistant to FK037 when compared with imipenem. Thus FK037 shows in-vitro and in-vivo activity against some methicillin-resistant staphylococcal species.
兔耐甲氧西林金黄色葡萄球菌引起的心内膜炎:体内和体外对β-内酰胺抗生素耐药性的表达。
DOI: --
发表时间: 1984
影响因子: 6.4
作者:
H. Chambers;C. Hackbarth;T. Drake;M. Rusnak;M. Sande
通讯作者: M. Sande
耐甲氧西林金黄色葡萄球菌的β-内酰胺耐药机制
DOI: --
发表时间: 1991
期刊:
影响因子: --
作者:
M. Franciolli;J. Billé;M. Glauser;P. Moreillon
通讯作者: P. Moreillon
广谱头孢菌素治疗甲氧西林敏感金黄色葡萄球菌实验性感染性心内膜炎的相对疗效
DOI: --
发表时间: 1993
影响因子: 4.9
作者:
J. Steckelberg;M. Rouse;B. Tallan;D. Osmon;N. Henry;W. Wilson
通讯作者: W. Wilson
阿莫西林克拉维酸、氯唑西林和万古霉素对大鼠甲氧西林敏感和耐甲氧西林金黄色葡萄球菌心内膜炎的疗效比较。
DOI: --
发表时间: 1989
影响因子: 6.4
作者:
L. Cantoni;A. Wenger;M. Glauser;Jacques Bille
通讯作者: Jacques Bille
替卡西林克拉维酸治疗大鼠实验性金黄色葡萄球菌心内膜炎的疗效
DOI: --
发表时间: 1992
影响因子: 4.9
作者:
E. Catherall;V. Gillon;S. Hurn;R. Irwin;L. Mizen
通讯作者: L. Mizen